North America Antacids Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Dosage Form (Tablet, Liquid, and Others); Drug Class (Proton Pump Inhibitors, H2 Antagonist, and Acid Neutralizers); Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy)

Market Introduction

The class of drugs that neutralize the acid in the stomach are known as antacids. It is used to treat conditions like heartburn, indigestion, acidity and an upset stomach. These drugs are available over the counter and are usually consumed by mouth. They are available in tablets, capsules, liquid and powder form. There are different types of antacid available like aluminium hydroxide, magnesium carbonate, magnesium trisilicate, magnesium hydroxide, calcium carbonate, and sodium bicarbonate.

Market Overview and Dynamics

The North America antacids market is expected to reach US$ 3,564.22 million in 2027 from US$ 2,684.67 million in 2019. The market is estimated to grow with a CAGR of 3.7% from 2020-2027. The growth of this market is estimated to grow owing to key driving factors such as the growing prevalence of gastroesophageal reflux disease (GERD) and the rising rate of incidence of obesity. However, the market is expected experiencing slow growth during the forecast period owing to the lack of awareness regarding gastrointestinal diseases in developing countries.

Key Market Segments

Based on dosage form, the antacids market is segmented into tablet, liquid, and others. Based on drug class, the antacids market is segmented into proton pump inhibitors, H2 antagonist, and acid neutralizers. Based on distribution channel, the antacids market, is segmented into hospital pharmacy, retail pharmacy, and online pharmacy.

Major Sources and Companies Listed

Some of the major primary and secondary sources for antacids market included in the report are the National Institute of Diabetes and Digestive and Kidney Diseases (2014), the National Ambulatory Medical Care Survey (2016), National Center for Health Statistics (NCHS), and others.

Reasons to buy the report

• To understand the North America antacids market landscape and identify market segments that are most likely to guarantee a strong return
• Stay ahead of the race by comprehending the ever-changing competitive landscape for antacids market
• Efficiently plan M&A and partnership deals in North America antacids market by identifying market segments with the most promising probable sales
• Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form antacids market
• Obtain market revenue forecast for market by various segments from 2019 to 2027 in North America region

NORTH AMERICA ANTACIDS MARKET SEGMENTATION

By Dosage Form

• Tablet
• Liquid
• Others

By Drug Class

• Proton Pump Inhibitors
• H2 Antagonist
• Acid Neutralizers
  • Magaldrate
  • Sucralfate
  • Others

By Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

By Country

• North America

• US
• Canada
• Mexico

Company Profiles

• Bayer AG
• GlaxoSmithKline plc
• Takeda Pharmaceutical Company Limited
• Sun Pharmaceutical Industries Ltd
• Sanofi
• Boehringer Ingelheim International GmbH
• Dr. Reddy's Laboratories
• Pfizer Inc
• Reckitt Benckiser Group Plc
• Procter & Gamble

1. Bayer AG
2. GlaxoSmithKline plc
3. Takeda Pharmaceutical Company Limited
4. Sun Pharmaceutical Industries Ltd
5. Sanofi
6. Boehringer Ingelheim International GmbH
7. Dr. Reddy's Laboratories
8. Pfizer Inc
9. Reckitt Benckiser Group Plc
10. Procter & Gamble

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America antacids market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the North America antacids market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth, offering developed and emerging markets.
• Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.